STAAR Surgical Company
STAA
$17.87
$0.472.70%
NASDAQ
| 03/28/2025 | 12/27/2024 | 09/27/2024 | 06/28/2024 | 03/29/2024 | |
|---|---|---|---|---|---|
| Net Income | -1,523.57% | -541.31% | 107.18% | 21.69% | -223.21% |
| Total Depreciation and Amortization | 88.92% | 95.96% | 30.83% | 5.04% | 10.45% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 140.44% | 171.32% | 6.36% | -9.76% | 29.80% |
| Change in Net Operating Assets | 74.80% | 25.07% | 16.42% | -17.48% | 217.74% |
| Cash from Operations | -126.45% | -97.99% | 163.87% | -65.13% | 525.60% |
| Capital Expenditure | 71.78% | -85.40% | 32.16% | -106.90% | -79.32% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 72.14% | -154.02% | -170.71% | -209.45% | 66.66% |
| Cash from Investing | 118.39% | -187.02% | -210.68% | -303.19% | 62.96% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -5.00% | -2.50% | -7.69% | -5.00% | 4.76% |
| Issuance of Common Stock | -92.92% | -90.20% | -77.17% | -74.81% | 904.72% |
| Repurchase of Common Stock | -4.39% | -10,800.00% | 100.00% | -23.70% | 33.53% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -123.37% | -129.97% | -77.28% | -87.48% | 398.02% |
| Foreign Exchange rate Adjustments | 130.52% | -201.50% | 541.28% | 25.17% | -9,470.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -29.35% | -135.69% | -187.89% | -761.05% | 1,075.06% |